TTUHSC researcher receives $1.76 million grant to investigate new pancreatic cancer treatment

With a survival rate in the single digits, pancreatic ductal adenocarcinoma (PDAC) is highly lethal. In fact, by the time PDAC is clinically diagnosed, it is already considered incurable via surgery or other means in up to 90% of patients.

Integrated Nanotherapeutics secures funds to develop T1D therapy

The initiative is part of the Industry Discovery and Development Partnership (IDDP) programme, Credit: PeopleImages.com – Yuri A/Shutterstock. Integrated Nanotherapeutics (INT) has secured funding from

September 10, 2024

Can App Data Link Sleep and Chronic Disease?; AI Model to Manage Diabetes

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

July 28, 2024

Acetazolamide May Help COPD Patients Reach New Heights

Acetazolamide may prevent some patients with chronic obstructive pulmonary disease (COPD) from suffering altitude-related adverse health effects (ARAHE) when traveling, a randomized controlled trial showed.

September 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.